Randomized, Multicentre, Double- Blind, Placebo Controlled Trial of Rosuvastatin 10 mg for Inhibition of Atherosclerosis Progression Assessed by Carotid Artery Ultrasound in HIV-positive Patients Treated With Antiretrovirals.

Trial Profile

Randomized, Multicentre, Double- Blind, Placebo Controlled Trial of Rosuvastatin 10 mg for Inhibition of Atherosclerosis Progression Assessed by Carotid Artery Ultrasound in HIV-positive Patients Treated With Antiretrovirals.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 May 2013

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Atherosclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 May 2013 Actual end date (Mar 2013) added as reported by ClinicalTrials.gov.
    • 26 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 29 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top